Haykowsky et al. reported left ventricular dilation and a reduction in LVEF in HER2 positive BC patients treated by adjuvant trastuzumab, despite aerobic exercise training during the first 4 months of trastuzumab therapy (61). Here, ERBB2 is linked to breast cancer.